Study explains genetics behind OA
A team of British researchers has identified a genetic change that may significantly increase a person's chances of developing osteoarthritis.
A team of British researchers has identified a genetic change that may significantly increase a person's chances of developing osteoarthritis. While a prescription to buy Celebrex is currently among the best treatments for the condition, the researchers said the finding could lead to new medications that cure the condition.
The University of Newcastle upon Tyne researchers found that an epigenetic change is responsible for the increased risk. Unlike genetic mutations, which are characterized by a miscoded section of DNA and are responsible for much of the known genetic links to disease, epigenetic changes deal with the degree to which a particular gene is expressed.
The study showed that low expression levels of one particular gene leads to increased production of an enzyme known as MMP13. This chemical has been shown in previous studies to attack joint tissue and play a role in the development of OA.
Findings from the study could lead to the development of new drugs for the condition, which will be particularly important in the near future as the population continues to age and millions of people develop joint pain, the researchers said.
See also ...
|IMPORTANT DISCLOSURE: All medical content and news articles on this website is supplied by an independent third party company. While the information can be useful, this website relies on others for its creation and cannot guarantee the accuracy, medical efficacy, or reliability of the information provided. In all circumstances, you should always seek the advice of your physician and/or other qualified health professional(s) for drug, medical condition, or treatment advice. This website does not provide any medical advice. The content provided on this website is not a substitute for professional medical advice, diagnosis or treatment.|